FDA To Look At Risks Of J&J, Amgen Anemia Drugs
The U.S. Food and Drug Administration has said that it likely will take another look at drugs made by Johnson & Johnson and Amgen Inc. in light of a clinical study...To view the full article, register now.
Already a subscriber? Click here to view full article